SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-17-002049
Filing Date
2017-04-13
Accepted
2017-04-13 12:59:06
Documents
1
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT backenroth-form4_041017.html 4  
1 OWNERSHIP DOCUMENT backenroth-form4_041017.xml 4 6008
  Complete submission text file 0001387131-17-002049.txt   7568
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 489 5TH AVE., 28TH FLOOR NEW YORK NY 10017
Business Address
Backenroth Samuel (Reporting) CIK: 0001579887 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 17760074